カテゴリー： QYResearch, 世界, 部品/材料

世界のHEPES溶液市場インサイト及び予測（純度98％、純度99％、純度99.5％）

◆英語タイトル：Global HEPES Solution Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX01015）◆商品コード：QY22JLX01015
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：128
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、HEPES溶液のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にHEPES溶液の世界市場のxxx％を占める「純度98％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「細胞培養」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
HEPES溶液の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのHEPES溶液市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

HEPES溶液のグローバル主要企業には、Avantor、Thermo Fisher、Merck、Lonza、Cytiva、Promega Corporation、MP Biomedicals、Spectrum Laboratory、Biological Industries、Cayman Chemical、SERVA Electrophoresis GmbH、Bio-Techne、BioSpectra、Corning、FUJIFILM Irvine Scientific, Inc.、Dojindo Laboratories、XZL Bio-Technology、Suzhou Yacoo Science、Haihang Chemical、Yunbang Bio-pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

HEPES溶液市場は、種類と用途によって区分されます。世界のHEPES溶液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度98％、純度99％、純度99.5％

【用途別セグメント】
細胞培養、タンパク質抽出、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- HEPES溶液製品概要
- 種類別市場（純度98％、純度99％、純度99.5％）
- 用途別市場（細胞培養、タンパク質抽出、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のHEPES溶液販売量予測2017-2028
- 世界のHEPES溶液売上予測2017-2028
- HEPES溶液の地域別販売量
- HEPES溶液の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別HEPES溶液販売量
- 主要メーカー別HEPES溶液売上
- 主要メーカー別HEPES溶液価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度98％、純度99％、純度99.5％）
- HEPES溶液の種類別販売量
- HEPES溶液の種類別売上
- HEPES溶液の種類別価格
・用途別市場規模（細胞培養、タンパク質抽出、その他）
- HEPES溶液の用途別販売量
- HEPES溶液の用途別売上
- HEPES溶液の用途別価格
・北米市場
- 北米のHEPES溶液市場規模（種類別、用途別）
- 主要国別のHEPES溶液市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのHEPES溶液市場規模（種類別、用途別）
- 主要国別のHEPES溶液市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のHEPES溶液市場規模（種類別、用途別）
- 主要国別のHEPES溶液市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のHEPES溶液市場規模（種類別、用途別）
- 主要国別のHEPES溶液市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのHEPES溶液市場規模（種類別、用途別）
- 主要国別のHEPES溶液市場規模（トルコ、サウジアラビア）
・企業情報
Avantor、Thermo Fisher、Merck、Lonza、Cytiva、Promega Corporation、MP Biomedicals、Spectrum Laboratory、Biological Industries、Cayman Chemical、SERVA Electrophoresis GmbH、Bio-Techne、BioSpectra、Corning、FUJIFILM Irvine Scientific, Inc.、Dojindo Laboratories、XZL Bio-Technology、Suzhou Yacoo Science、Haihang Chemical、Yunbang Bio-pharmaceutical
・産業チェーン及び販売チャネル分析
- HEPES溶液の産業チェーン分析
- HEPES溶液の原材料
- HEPES溶液の生産プロセス
- HEPES溶液の販売及びマーケティング
- HEPES溶液の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- HEPES溶液の産業動向
- HEPES溶液のマーケットドライバー
- HEPES溶液の課題
- HEPES溶液の阻害要因
・主な調査結果

HEPES (N-(2-Hydroxyethyl)piperazine-N’-2-ethanesulfonic Acid)) Buffers is a zwitterionic organic chemical buffering agent. HEPES Buffers is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.
Market Analysis and Insights: Global HEPES Solution Market
Due to the COVID-19 pandemic, the global HEPES Solution market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity 98% accounting for % of the HEPES Solution global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cell Culture segment is altered to an % CAGR throughout this forecast period.
China HEPES Solution market size is valued at US$ million in 2021, while the US and Europe HEPES Solution are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe HEPES Solution landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of HEPES Solution include Avantor, Thermo Fisher, Merck, Lonza, Cytiva, Promega Corporation, MP Biomedicals, Spectrum Laboratory and Biological Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the HEPES Solution capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of HEPES Solution by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global HEPES Solution Scope and Segment
HEPES Solution market is segmented by Type and by Application. Players, stakeholders, and other participants in the global HEPES Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity 98%
Purity 99%
Purity 99.5%
Segment by Application
Cell Culture
Protein Extraction
Others
By Company
Avantor
Thermo Fisher
Merck
Lonza
Cytiva
Promega Corporation
MP Biomedicals
Spectrum Laboratory
Biological Industries
Cayman Chemical
SERVA Electrophoresis GmbH
Bio-Techne
BioSpectra
Corning
FUJIFILM Irvine Scientific, Inc.
Dojindo Laboratories
XZL Bio-Technology
Suzhou Yacoo Science
Haihang Chemical
Yunbang Bio-pharmaceutical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 HEPES Solution Product Introduction
1.2 Market by Type
1.2.1 Global HEPES Solution Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity 98%
1.2.3 Purity 99%
1.2.4 Purity 99.5%
1.3 Market by Application
1.3.1 Global HEPES Solution Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Cell Culture
1.3.3 Protein Extraction
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global HEPES Solution Production
2.1 Global HEPES Solution Production Capacity (2017-2028)
2.2 Global HEPES Solution Production by Region: 2017 VS 2021 VS 2028
2.3 Global HEPES Solution Production by Region
2.3.1 Global HEPES Solution Historic Production by Region (2017-2022)
2.3.2 Global HEPES Solution Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global HEPES Solution Sales in Volume & Value Estimates and Forecasts
3.1 Global HEPES Solution Sales Estimates and Forecasts 2017-2028
3.2 Global HEPES Solution Revenue Estimates and Forecasts 2017-2028
3.3 Global HEPES Solution Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global HEPES Solution Sales by Region
3.4.1 Global HEPES Solution Sales by Region (2017-2022)
3.4.2 Global Sales HEPES Solution by Region (2023-2028)
3.5 Global HEPES Solution Revenue by Region
3.5.1 Global HEPES Solution Revenue by Region (2017-2022)
3.5.2 Global HEPES Solution Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global HEPES Solution Production Capacity by Manufacturers
4.2 Global HEPES Solution Sales by Manufacturers
4.2.1 Global HEPES Solution Sales by Manufacturers (2017-2022)
4.2.2 Global HEPES Solution Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of HEPES Solution in 2021
4.3 Global HEPES Solution Revenue by Manufacturers
4.3.1 Global HEPES Solution Revenue by Manufacturers (2017-2022)
4.3.2 Global HEPES Solution Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by HEPES Solution Revenue in 2021
4.4 Global HEPES Solution Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global HEPES Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global HEPES Solution Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global HEPES Solution Sales by Type
5.1.1 Global HEPES Solution Historical Sales by Type (2017-2022)
5.1.2 Global HEPES Solution Forecasted Sales by Type (2023-2028)
5.1.3 Global HEPES Solution Sales Market Share by Type (2017-2028)
5.2 Global HEPES Solution Revenue by Type
5.2.1 Global HEPES Solution Historical Revenue by Type (2017-2022)
5.2.2 Global HEPES Solution Forecasted Revenue by Type (2023-2028)
5.2.3 Global HEPES Solution Revenue Market Share by Type (2017-2028)
5.3 Global HEPES Solution Price by Type
5.3.1 Global HEPES Solution Price by Type (2017-2022)
5.3.2 Global HEPES Solution Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global HEPES Solution Sales by Application
6.1.1 Global HEPES Solution Historical Sales by Application (2017-2022)
6.1.2 Global HEPES Solution Forecasted Sales by Application (2023-2028)
6.1.3 Global HEPES Solution Sales Market Share by Application (2017-2028)
6.2 Global HEPES Solution Revenue by Application
6.2.1 Global HEPES Solution Historical Revenue by Application (2017-2022)
6.2.2 Global HEPES Solution Forecasted Revenue by Application (2023-2028)
6.2.3 Global HEPES Solution Revenue Market Share by Application (2017-2028)
6.3 Global HEPES Solution Price by Application
6.3.1 Global HEPES Solution Price by Application (2017-2022)
6.3.2 Global HEPES Solution Price Forecast by Application (2023-2028)
7 North America
7.1 North America HEPES Solution Market Size by Type
7.1.1 North America HEPES Solution Sales by Type (2017-2028)
7.1.2 North America HEPES Solution Revenue by Type (2017-2028)
7.2 North America HEPES Solution Market Size by Application
7.2.1 North America HEPES Solution Sales by Application (2017-2028)
7.2.2 North America HEPES Solution Revenue by Application (2017-2028)
7.3 North America HEPES Solution Sales by Country
7.3.1 North America HEPES Solution Sales by Country (2017-2028)
7.3.2 North America HEPES Solution Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe HEPES Solution Market Size by Type
8.1.1 Europe HEPES Solution Sales by Type (2017-2028)
8.1.2 Europe HEPES Solution Revenue by Type (2017-2028)
8.2 Europe HEPES Solution Market Size by Application
8.2.1 Europe HEPES Solution Sales by Application (2017-2028)
8.2.2 Europe HEPES Solution Revenue by Application (2017-2028)
8.3 Europe HEPES Solution Sales by Country
8.3.1 Europe HEPES Solution Sales by Country (2017-2028)
8.3.2 Europe HEPES Solution Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific HEPES Solution Market Size by Type
9.1.1 Asia Pacific HEPES Solution Sales by Type (2017-2028)
9.1.2 Asia Pacific HEPES Solution Revenue by Type (2017-2028)
9.2 Asia Pacific HEPES Solution Market Size by Application
9.2.1 Asia Pacific HEPES Solution Sales by Application (2017-2028)
9.2.2 Asia Pacific HEPES Solution Revenue by Application (2017-2028)
9.3 Asia Pacific HEPES Solution Sales by Region
9.3.1 Asia Pacific HEPES Solution Sales by Region (2017-2028)
9.3.2 Asia Pacific HEPES Solution Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America HEPES Solution Market Size by Type
10.1.1 Latin America HEPES Solution Sales by Type (2017-2028)
10.1.2 Latin America HEPES Solution Revenue by Type (2017-2028)
10.2 Latin America HEPES Solution Market Size by Application
10.2.1 Latin America HEPES Solution Sales by Application (2017-2028)
10.2.2 Latin America HEPES Solution Revenue by Application (2017-2028)
10.3 Latin America HEPES Solution Sales by Country
10.3.1 Latin America HEPES Solution Sales by Country (2017-2028)
10.3.2 Latin America HEPES Solution Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa HEPES Solution Market Size by Type
11.1.1 Middle East and Africa HEPES Solution Sales by Type (2017-2028)
11.1.2 Middle East and Africa HEPES Solution Revenue by Type (2017-2028)
11.2 Middle East and Africa HEPES Solution Market Size by Application
11.2.1 Middle East and Africa HEPES Solution Sales by Application (2017-2028)
11.2.2 Middle East and Africa HEPES Solution Revenue by Application (2017-2028)
11.3 Middle East and Africa HEPES Solution Sales by Country
11.3.1 Middle East and Africa HEPES Solution Sales by Country (2017-2028)
11.3.2 Middle East and Africa HEPES Solution Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Avantor
12.1.1 Avantor Corporation Information
12.1.2 Avantor Overview
12.1.3 Avantor HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Avantor HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Avantor Recent Developments
12.2 Thermo Fisher
12.2.1 Thermo Fisher Corporation Information
12.2.2 Thermo Fisher Overview
12.2.3 Thermo Fisher HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Thermo Fisher HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Thermo Fisher Recent Developments
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Overview
12.3.3 Merck HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Merck HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Merck Recent Developments
12.4 Lonza
12.4.1 Lonza Corporation Information
12.4.2 Lonza Overview
12.4.3 Lonza HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Lonza HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Lonza Recent Developments
12.5 Cytiva
12.5.1 Cytiva Corporation Information
12.5.2 Cytiva Overview
12.5.3 Cytiva HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Cytiva HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Cytiva Recent Developments
12.6 Promega Corporation
12.6.1 Promega Corporation Corporation Information
12.6.2 Promega Corporation Overview
12.6.3 Promega Corporation HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Promega Corporation HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Promega Corporation Recent Developments
12.7 MP Biomedicals
12.7.1 MP Biomedicals Corporation Information
12.7.2 MP Biomedicals Overview
12.7.3 MP Biomedicals HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 MP Biomedicals HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 MP Biomedicals Recent Developments
12.8 Spectrum Laboratory
12.8.1 Spectrum Laboratory Corporation Information
12.8.2 Spectrum Laboratory Overview
12.8.3 Spectrum Laboratory HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Spectrum Laboratory HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Spectrum Laboratory Recent Developments
12.9 Biological Industries
12.9.1 Biological Industries Corporation Information
12.9.2 Biological Industries Overview
12.9.3 Biological Industries HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Biological Industries HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Biological Industries Recent Developments
12.10 Cayman Chemical
12.10.1 Cayman Chemical Corporation Information
12.10.2 Cayman Chemical Overview
12.10.3 Cayman Chemical HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Cayman Chemical HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Cayman Chemical Recent Developments
12.11 SERVA Electrophoresis GmbH
12.11.1 SERVA Electrophoresis GmbH Corporation Information
12.11.2 SERVA Electrophoresis GmbH Overview
12.11.3 SERVA Electrophoresis GmbH HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 SERVA Electrophoresis GmbH HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 SERVA Electrophoresis GmbH Recent Developments
12.12 Bio-Techne
12.12.1 Bio-Techne Corporation Information
12.12.2 Bio-Techne Overview
12.12.3 Bio-Techne HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Bio-Techne HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Bio-Techne Recent Developments
12.13 BioSpectra
12.13.1 BioSpectra Corporation Information
12.13.2 BioSpectra Overview
12.13.3 BioSpectra HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 BioSpectra HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 BioSpectra Recent Developments
12.14 Corning
12.14.1 Corning Corporation Information
12.14.2 Corning Overview
12.14.3 Corning HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Corning HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Corning Recent Developments
12.15 FUJIFILM Irvine Scientific, Inc.
12.15.1 FUJIFILM Irvine Scientific, Inc. Corporation Information
12.15.2 FUJIFILM Irvine Scientific, Inc. Overview
12.15.3 FUJIFILM Irvine Scientific, Inc. HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 FUJIFILM Irvine Scientific, Inc. HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 FUJIFILM Irvine Scientific, Inc. Recent Developments
12.16 Dojindo Laboratories
12.16.1 Dojindo Laboratories Corporation Information
12.16.2 Dojindo Laboratories Overview
12.16.3 Dojindo Laboratories HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Dojindo Laboratories HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Dojindo Laboratories Recent Developments
12.17 XZL Bio-Technology
12.17.1 XZL Bio-Technology Corporation Information
12.17.2 XZL Bio-Technology Overview
12.17.3 XZL Bio-Technology HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 XZL Bio-Technology HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 XZL Bio-Technology Recent Developments
12.18 Suzhou Yacoo Science
12.18.1 Suzhou Yacoo Science Corporation Information
12.18.2 Suzhou Yacoo Science Overview
12.18.3 Suzhou Yacoo Science HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Suzhou Yacoo Science HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Suzhou Yacoo Science Recent Developments
12.19 Haihang Chemical
12.19.1 Haihang Chemical Corporation Information
12.19.2 Haihang Chemical Overview
12.19.3 Haihang Chemical HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 Haihang Chemical HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Haihang Chemical Recent Developments
12.20 Yunbang Bio-pharmaceutical
12.20.1 Yunbang Bio-pharmaceutical Corporation Information
12.20.2 Yunbang Bio-pharmaceutical Overview
12.20.3 Yunbang Bio-pharmaceutical HEPES Solution Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 Yunbang Bio-pharmaceutical HEPES Solution Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Yunbang Bio-pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 HEPES Solution Industry Chain Analysis
13.2 HEPES Solution Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 HEPES Solution Production Mode & Process
13.4 HEPES Solution Sales and Marketing
13.4.1 HEPES Solution Sales Channels
13.4.2 HEPES Solution Distributors
13.5 HEPES Solution Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 HEPES Solution Industry Trends
14.2 HEPES Solution Market Drivers
14.3 HEPES Solution Market Challenges
14.4 HEPES Solution Market Restraints
15 Key Finding in The Global HEPES Solution Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のHEPES溶液市場インサイト及び予測（純度98％、純度99％、純度99.5％）(Global HEPES Solution Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のカリウムシリコフルオリド市場インサイト及び予測（純度98％、純度99％、純度99.9％、その他）
  • 世界のベンゼンチオール溶液市場インサイト及び予測（純度98%-99%、純度99%以上）
  • 世界のHEPESバッファー市場インサイト及び予測（純度98％、純度99％、純度99.5％）
  • 世界の2-エチルブタナール市場インサイト及び予測（純度98％以下、純度98％〜99％、純度99％以上）
  • 世界の2-エチル酪酸市場インサイト及び予測（純度98％以下、純度98％〜99％、純度99％以上）